Real-time Adaptive Particle Therapy of Cancer (RAPTOR)
RAPTOR brings together 13 Beneficiaries and 15 partner organizations with one aim in common: To bring adaptive particle therapy to the clinic.
Introduction
The high precision of particle therapy (PT) comes as a double-edged sword since PT is normally less robust than X-ray radiotherapy. Several uncertainties, such as changes in anatomy, positioning, organ delineation and systematic uncertainties can have a significant impact on where the final dose is delivered. The reliability of PT has increased in recent years with robust treatment planning, however, it still remains sensitive to larger uncertainties that have to be minimized to exploit the full benefit of PT.
The clinical workflow in PT has been adopted from conventional X-ray radiotherapy, where the treatment plan is based on the initial computed tomography (CT) scan of a patient. Since, the treatment usually lasts several weeks, it is likely that the initial treatment plan becomes less valid due to the changes of the patient anatomy as the treatment progresses.
We propose a shift in the paradigm
- Preparing a daily PT treatment plan for each patient, that is based on current patient images, would significantly increase treatment accuracy since most of the uncertainties would be minimized.
- The advantages of PT could be better utilized in an interventional capacity.
- Due to its flexibility and rapid adaptation, RAPTOR will enable treating patients in the sitting and standing positions, which will facilitate simpler, more compact, and less costly beamline designs.
- RAPTOR will therefore make the benefits of proton therapy available to many more patients.
Our research projects
News & Articles
PHD position in Bergen, Norway on range verification and adaptive proton therapy
We are announcing an opportunity to join the NOVO project – Next generation imaging for real-time dose verification enabling adaptive proton therapy (financed by the
🚀 RAPTOR FINAL CONFERENCE 🚀
At the RAPTOR Final Conference, our primary objective is to showcase the outcomes of the Early Stage Researcher (ESR) projects within our consortium. Moreover, we aim
Newsletter RAPTOR n*4, December 2023
Welcome to the fourth issue of the RAPTOR newsletter! The newest edition focuses on the 3rd RAPTOR School, which took place in Switzerland in September 2023.
PHD position in Bergen, Norway on range verification and adaptive proton therapy
We are announcing an opportunity to join the NOVO project – Next generation imaging for real-time dose verification enabling adaptive proton therapy (financed by the
🚀 RAPTOR FINAL CONFERENCE 🚀
At the RAPTOR Final Conference, our primary objective is to showcase the outcomes of the Early Stage Researcher (ESR) projects within our consortium. Moreover, we aim
Newsletter RAPTOR n*4, December 2023
Welcome to the fourth issue of the RAPTOR newsletter! The newest edition focuses on the 3rd RAPTOR School, which took place in Switzerland in September 2023.
Newsletter RAPTOR n* 3, July 2023
Welcome to the third issue of the RAPTOR newsletter! In this edition, we have focused on the results of the work package (WP) 2, “Imaging.”
Member of RAPTOR Consortium
RAPTOR brings together 13 Beneficiaries and 15 partner organizations from all over Europe with one aim in common: To bring adaptive particle therapy to the clinic.